Table of Contents:
I.Short Course on the Genetics of Addiction
II. Request for Administrative Supplements for Basic Research on Opioids to Existing Grant Awards (NOT-DA-18-014)
III. Genetic analysis of non-human animal models to understand the genomic architecture of substance use disorders and addictive behaviors (U01 Clinical Trial Not Allowed) (PAR-18-789)
IV. U.S. – Japan Brain Research Cooperative Program (BRCPP) Administrative Supplements (PA-17-326
---
I.Short Course on the Genetics of Addiction
September 16-22, 2018
The Jackson Laboratory, Bar Harbor, Maine
Registration Fee: $1300 registration fee includes all course materials, meals and shared lodging. Scholarships are available.
More information: https://www.jax.org/education-and-learning/education-calendar/2018/september/short-course-on-the-genetics-of-addiction
Apply Online at: https://www.regonline.com/18Addiction-Application
This JAX short course brings together world-renowned experts in addiction, human genetics, and mouse genetics. Through a combination of lectures and hands-on computational modules, the course will feature:
- New methods and applications of mouse genetics to addiction,
- Genetic and bioinformatics approaches to augment behavioral studies, and
- Techniques for analyzing human genetic studies of addiction.
The course also provides key opportunities to network with students, researchers, and other professionals; and explore potential scientific collaborations.
Supported by R13DA032192
II. Request for Administrative Supplements for Basic Research on Opioids to Existing Grant Awards (NOT-DA-18-014)
In response to the opioid epidemic, the Division of Neuroscience and Behavior is requesting the submission of administrative supplements for basic research on opioids to existing grant applications. To rapidly facilitate basic research that will enhance our ability to prevent or treat opioid abuse, overdose, addiction and/or relapse, DNB is requesting the submission of administrative supplements for basic research on opioids to existing R01 or project grant applications that are not currently focused on opioids. Requests for supplements in the last year of the grant will not be considered. This notice is effective until August 2019.
Before submitting, grantees are encouraged to discuss a potential submission of an administrative supplement request with NIDA Program and Grants Management specialist. The telephone number and email address of your NIDA Program Officer and your NIDA Grants Specialist are available in the eRA Commons, on your Notice of Award, and are also available here, at NIH NED.
NIDA staff will review the application and consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research. The parent grant must remain active for the entire period of the supplemental funding. Please note that a no-cost extension cannot be used to accommodate this requirement. All no-cost extensions must be in place prior to submitting a request for an administrative supplement. In some cases, additional expertise may be called upon to assist in the review. Administrative supplement requests above $100,000 in direct costs will also be reviewed by the National Advisory Council on Drug Abuse.
Please direct all inquiries to:
Roger Little, Ph.D.
National Institute on Drug Abuse
Telephone: 301-435-1316
Email: Roger.Little@nih.gov
-----------------------
III. Genetic analysis of non-human animal models to understand the genomic architecture of substance use disorders and addictive behaviors (U01 Clinical Trial Not Allowed) PAR-18-789
Application due dates: August 21, 2018, March 19, 2019; August 21, 2019, March 19, 2020; August 21, 2020, March 19, 2021, by 5:00 PM local time of applicant organization.
The goals of this initiative are to discover allelic variants, genomic alterations, and functional changes associated with addictive behaviors in non-human animals through systems studies that employ genetic and genomics strategies. We also encourage applications that take genetic and/or genomics approaches to integrate data, delineate gene networks, and uncover the function of known or newly discovered genetic or epigenetic variants.
Investigators examining the phenotype of knockout mice are discouraged from submitting applications to this FOA. Instead, they should submit applications in response PA-17-155 (R01) PA-17-157 (R21) Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders
Please direct all inquiries to:
Amy Lossie, Ph.D.
Telephone 301.827.6092
Email: amy.lossie@nih.gov
----------
IV. U.S. – Japan Brain Research Cooperative Program (BRCPP) Administrative Supplements (PA-17-326)
The National Institutes of Health (NIH) announces the continuation of the U.S. entity of the U.S.-Japan Brain Research Cooperative Program (BRCP). This administrative supplement program will provide funds to research projects that are currently supported by the participating NIH Institutes and Centers.
The purpose of the BRCP is to promote scientist exchange, training, and collaborations in basic, translational and clinical research between neuroscientists from the U.S. and Japan.
The U.S. entity of the BRCP supports the following activities:
1) Visit of U.S. scientists to conduct collaborative research and/or to acquire advanced research skills in Japanese institutions.
2) Joint workshops to exchange scientific information and to foster collaborations.
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov
Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact
jpollock@mail.nih.gov 301-435-1309
No comments:
Post a Comment